|
IDT concludes GeneWorks oligo acquisition
March 2017
SHARING OPTIONS:
SKOKIE, Ill.—Integrated
DNA Technologies (IDT) announced in February that it had completed, through its Singapore subsidiary, its acquisition of GeneWorks Pty Ltd.’s oligonucleotide manufacturing business in Australia. The
deal expands IDT’s footprint and sales options within the Asia-Pacific region, and as a leader in custom nucleic acid synthesis, IDT can provide
GeneWorks customers with a variety of manufacturing options for oligos and other high-quality products for genomics research. Following the transaction,
GeneWorks will continue to provide molecular and cell biology products and associated services.
“With this
acquisition, we are furthering our goal of making our world-class products and services more easily accessible to scientists around the world. We look
forward to availing GeneWorks’ customers of our unrivaled manufacturing capabilities, design expertise and fast turnaround times,” remarked Dr.
Joseph A Walder, founder and CEO of IDT.
Back |
Home |
FAQs |
Search |
Submit News Release |
Site Map |
About Us |
Advertising |
Resources |
Contact Us |
Terms & Conditions |
Privacy Policy
|